Quick Quiz: Immunotherapy in Cancer Edition

Immunotherapy has transformed the foundation of cancer care, and according to the American Association for Cancer Research, it’s one of the 5 pillars of cancer treatment. How much do you know about immunotherapy? Test your knowledge here.

References

1. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711-723. doi:10.1056/NEJMoa1003466
2. Reck M, Rodríguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer. N Engl J Med. 2016;375:1823-1833. doi:10.1056/NEJMoa1606774
3. Halim L, Maher J. CAR T-cell immunotherapy of B-cell malignancy: the story so far. Ther Adv Vaccines Immunother. 2020;8:2515135520927164. doi:10.1177/2515135520927164
4. Underwood PW, Ruff SM, Pawlik TM. Update on targeted therapy and immunotherapy for metastatic colorectal cancer. Cells. 2024;13:245. doi:10.3390/cells13030245
5. Zhou S, Liu M, Ren F, et al. The landscape of bispecific T cell engager in cancer treatment. Biomark Res. 2021;9:38. doi:10.1186/s40364-021-00294-9